Table 1.
Baseline characteristics
| Participants without psoriasis (N=12) | Participants with psoriasis (N=13) | Participants with psoriasis who received NBUVB treatment (N=7) | Compared data in column 1 and column 2- value | |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | P-value | |
| Age (years) | 43.7±7.18 | 39.6±11.25 | 39.0±11.72 | 0.299 *® |
| Sex | 0.673*© | |||
| Male (%) | 8 (66.67%) | 10 (76.9%) | 6 (85.71%) | |
| Female (%) | 4 (33.33%) | 3 (23.08%) | 1 (14.28%) | |
| BMI (kg/m2) | 24.11±4.28 | 25.08±6.10 | 26.74±7.70 | 0.653*® |
| PASI | N/A | 17.6±8.52 | 17.38±8.63 | |
| VAS (1–10) | N/A | 4.02±2.39 | 4.59±2.30 | |
| ISS (0–21) | N/A | 6.89±2.04 | 7.75±2.75 | |
| Smoking | 1*© | |||
| Yes | 0 | 1(7.69%) | 1(14.28%) | |
| No | 13 (100%) | 12 (92.31%) | 6 (85.71%) | |
| Alcohol drinking | 1*© | |||
| Yes | 0 | 1 (7.69%) | 1 (7.69%) | |
| No | 13 (100%) | 12 (92.31%) | 12 (92.31%) | |
| Age of onset (years) | N/A | 30.26±15.32 | 28.29±15.68 | |
| Skin lesion | N/A | 13 (100%) | 7 (100%) | |
| Scalp lesion | N/A | 10 (76.92%) | 7 (100%) | |
| Nail lesion | N/A | 10 (76.92%) | 5 (71.42%) | |
| Family history of psoriasis | N/A | 3 (23.08%) | 3 (42.85%) | |
| Underlying disease | ||||
| None | 11(91.66%) | 11 (84.61%) | 6 (85.71%) | 1*© |
| Hypertension | 1 (8.33%) | 1 (7.69%) | 1 (14.29%) | |
| Allergy | 0 | 1 (7.69%) | 0 |
Notes: Values presented as frequency (%), Mean ± SD. *® resulted from two-independent sample t-test. *© resulted from Fisher’s exact test.
Abbreviations: BMI, body mass index; PASI, psoriasis area and severity index; VAS, visual analog scale; ISS, itch severity index.